Early Detection Research Network

Biomarkers: the key to early detection

You are here: Home › Protocols › Aurora Kinase A as a Biomarker for the Detection of Bladder Cancer - Supplemental Pre-Validation Protocol

Abbreviated Name: Aurora Kinase A as a Biomarker for the Detection of Bladder Cancer

Protocol ID: 232

Lead Investigator: Czerniak, Bogdan — The University of Texas MD Anderson Cancer Center

Coordinating Investigator: Czerniak, Bogdan — The University of Texas MD Anderson Cancer Center

Involved Investigator Sites:

Biomarker Name:

Design:

Field(s) of Research: UNKNOWN

Collaborative Group Text: Prostate and Urologic Cancers Research Group

Phased Status:

Description:

Abstract:

Aims:

Analytic Method:

Comments:

Biomarkers:

There are currently no biomarkers annotated for this protocol.

Datasets:

No datasets are currently associated with this protocol.